Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8312)
All Articles published online
|
Publishing Process of This Article
|
Jul 18, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tampaki M, Doumba PP, Deutsch M, Koskinas J. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights. World J Hepatol 2015; 7(14): 1834-1842 [PMID: 26207165 DOI: 10.4254/wjh.v7.i14.1834] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i14/1834.htm |
| Number | Citing Articles |
| 1 |
M. Milovancev, D. S. Russell. Surgical margins in the veterinary cancer patient. Veterinary and Comparative Oncology 2017; 15(4): 1136 doi: 10.1111/vco.12284
|
| 2 |
Malkhaz Mizandari, Natela Paksashvili, Nino Kikodze, Tamta Azrumelashvili, Ia Pantsulaia, Koba Shanava, Nona Janikashvili, Tinatin Chikovani. Long-term survival in a patient with low-level inflammatory markers and liver metastasis, converted resectable by TACE. Immunotherapy 2017; 9(13): 1067 doi: 10.2217/imt-2017-0069
|
| 3 |
Wan-Joon Kim, Tae-Wan Lim, Pyoung-Jae Park, Sae-Byeol Choi, Wan-Bae Kim. Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection. The International Journal of Biological Markers 2019; 34(2): 123 doi: 10.1177/1724600819834306
|
| 4 |
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017
|
| 5 |
Sophia Kästle, Matthias R. Stechele, Lisa Richter, Regina Schinner, Elif Öcal, Marianna Alunni-Fabbroni, Enrico De Toni, Stefanie Corradini, Max Seidensticker, S. Nahum Goldberg, Jens Ricke, Moritz Wildgruber, Melanie A. Kimm. Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(12): 9777 doi: 10.1007/s00432-023-04875-z
|
| 6 |
Yang Zhao, Tongwang Yang, Yabo Ouyang, Wei Rao, Kai Liu, Jiasheng Zheng, Fudong Lv, Ying Shi, Feng Wang, Dongjie Liu, Luxin Qiao, Zhenying Xia, Yushi Zhang, Dexi Chen, Wenjing Wang. Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1339213
|
| 7 |
Swathi Mohankumar, Tushar Patel. Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancer. Briefings in Functional Genomics 2016; 15(3): 249 doi: 10.1093/bfgp/elv058
|
| 8 |
Cody R. Criss, Mina S. Makary. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors. Biology 2023; 12(7): 999 doi: 10.3390/biology12070999
|
| 9 |
Zhizhou Huang, Xueqiong Zhou, Yangfan He, Xiangyu Ke, Ying Wen, Fei Zou, Xuemei Chen. Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transition. Scientific Reports 2016; 6(1) doi: 10.1038/srep38072
|
| 10 |
Cheng-Shi Chen, Fang-Kun Li, Chen-Yang Guo, Jin-Cheng Xiao, Hong-Tao Hu, Hong-Tao Cheng, Lin Zheng, Deng-Wei Zong, Jun-Li Ma, Li Jiang, Hai-Liang Li. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Oncotarget 2016; 7(6): 7241 doi: 10.18632/oncotarget.6892
|
| 11 |
Hana Park, Jae Hyung Jung, Min Kyung Jung, Eui-Cheol Shin, Simon Weonsang Ro, Jeon Han Park, Do Young Kim, Jun Yong Park, Kwang-Hyub Han. Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma. Hepatology International 2020; 14(2): 249 doi: 10.1007/s12072-020-10014-4
|
| 12 |
Norhanan Hamzah, Nur Karyatee Kassim, Julia Omar, Mohd Shafie Abdullah, Yeong Yeh Lee. Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions. PeerJ 2023; 11: e15988 doi: 10.7717/peerj.15988
|
| 13 |
Changjiang Lei, Defa Ren, Meixia Fu, Chuantao Sun, Hong Ren, Qingyun Pan, Yuan Li. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells. Oncology Letters 2019; doi: 10.3892/ol.2019.10022
|
| 14 |
Masoud Nouri‐Vaskeh, Leila Alizadeh, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh, Monireh Halimi, Behzad Baradaran. The role of HSP90 molecular chaperones in hepatocellular carcinoma. Journal of Cellular Physiology 2020; 235(12): 9110 doi: 10.1002/jcp.29776
|
| 15 |
Anne-Laure Grindel, Nathalie Fretellier, Miguel Soares, Nabiha Bouzakher, Vincent Millot Maysounabe, Robin Santus, Olivia Bawa, Melody Wintrebert, Clémence Couquelet, Philippe Robert, Jean-Francois Emile, Claude Capron. Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinoma. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1272246
|